HLB Pharmaceutical Co. Ltd (047920) — Free Cash Flow Generation Index
HLB Pharmaceutical Co. Ltd (047920) has a Free Cash Flow Generation Index of -0.21x as of September 2025. Free cash flow of ₩-391.04 Million represents 0% of operating cash flow (₩1.86 Billion). Read 047920 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
HLB Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for HLB Pharmaceutical Co. Ltd across 3 annual periods. Explore HLB Pharmaceutical Co. Ltd (047920) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for HLB Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for HLB Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 047920 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | ₩3.75 Billion | ₩6.84 Billion | ₩3.09 Billion | ▼ -73.0% |
| 2019 | 2.03x | ₩2.75 Billion | ₩1.35 Billion | ₩1.40 Billion | ▼ -17.6% |
| 2014 | 2.47x | ₩3.80 Billion | ₩1.54 Billion | ₩2.26 Billion | — |